Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial.

Radiat Oncol · 2022 · PMC9011377 · PMID 35428327

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

For PACE-B early toxicity results are available, showing no significant difference between the treatment arms with a slight trend in favor of the SBRT regime (23% vs. 27%) [ 38 ].

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.